Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › Billing code M0241

M0241

Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency, subsequent repeat doses

Medicaid paid $6.84M on code M0241 from 2018 through 2024, to 9 providers — the #2,309 code in the file by dollars. 88% of it was billed in Texas.

28Total paid$6.84M
24GClaims51,339
Paid per claim line$133.19
33Providers billing it9
Box 32 · Location

Where M0241 is billed

  1. $6.0M
  2. $822K
  3. $3.1K

The largest of 3 states and territories, by the billing provider's address. States cover different services and set their own rates, so the same code can mean different things in different programs.

Ranked

Top providers billing M0241

#ProviderLocationClaimsPaid on M0241
1 Segnik Group INC Houston, TX 15,384 $1.75M
2 Consumer Directed Services in Texas, INC. San Antonio, TX 4,670 $1.72M
3 Alamo Consumer Direct, LLC Austin, TX 12,699 $1.22M
4 Acumen Fiscal Agent LLC Mesa, AZ 6,787 $822K
5 Eak Good Neighbor Properties Mount Vernon, TX 4,369 $477K
6 Helping Restore Ability Arlington, TX 3,934 $436K
7 Community Access, INC Tyler, TX 2,017 $214K
8 Nzeadibe, Geoffrey Garland, TX 1,466 $200K
9 Medical Director Services PC Bronx, NY 13 $3K